Soligenix, Inc. Common Stock (SNGX) Stock Price, Quote & AI Analysis

Live SNGX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Soligenix, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Soligenix, Inc. Common Stock (SNGX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

SNGX
Soligenix, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
1.120000
High
1.130000
Low
1.080000
Volume
63,202
VWAP
-
Market Cap
$13,817,998.10
52W Range
$1.02 - $6.23
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 19, 2026 Q4
After Hours
EPS Estimate: $-0.5712
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Soligenix, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Soligenix, Inc. Common Stock Overview

Company information

Company Overview

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Company Details
Market Cap
$10.99M
Shares Outstanding
10,086,131
Weighted Shares Outstanding
10,086,130
CEO
Christopher J. Schaber
Address
29 EMMONS DRIVE, PRINCETON, NJ, 08540
Employees
16
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Soligenix, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...